244 related articles for article (PubMed ID: 20548274)
21. [Exploration on neoadjuvant chemoradiation in the treatment for locally advanced low rectal cancer].
Yu BM; Zhang M; Peng LH; Bian GW; Wu WQ; Chen LW; Fu J; Fei CS
Zhonghua Wai Ke Za Zhi; 2009 Oct; 47(20):1540-3. PubMed ID: 20092741
[TBL] [Abstract][Full Text] [Related]
22. Multimodality management of locally advanced rectal cancer.
Moore HG; Guillem JG
Am Surg; 2003 Jul; 69(7):612-9. PubMed ID: 12889627
[TBL] [Abstract][Full Text] [Related]
23. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.
Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J
Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512
[TBL] [Abstract][Full Text] [Related]
24. Management of rectal cancer: strategies and controversies.
Jagad RB; Koshariya M; Kawamoto J; Papastratis P; Kefalourous H; Patris V; Tzouma C; Lygidakis NJ
Hepatogastroenterology; 2008; 55(81):82-92. PubMed ID: 18507084
[TBL] [Abstract][Full Text] [Related]
25. Combined-modality therapy with sphincter-preserving total mesorectal excision for locally advanced rectal cancer: patient's age and long-term outcome.
Szynglarewicz B; Matkowski R; Maciejczyk A; Kasprzak P; Forgacz J; Pudelko M
J Gastrointestin Liver Dis; 2008 Mar; 17(1):49-52. PubMed ID: 18392244
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer.
Rodríguez-Ramírez SE; Uribe A; Ruiz-García EB; Labastida S; Luna-Pérez P
Rev Invest Clin; 2006; 58(3):204-10. PubMed ID: 16958295
[TBL] [Abstract][Full Text] [Related]
27. Low anterior resection: alternative anastomotic techniques.
Schoetz DJ; Ricciardi R
Surg Oncol Clin N Am; 2010 Oct; 19(4):761-75. PubMed ID: 20883952
[TBL] [Abstract][Full Text] [Related]
28. Sphincter preservation therapy for rectal cancer.
Aitken C; Breen E; Mamon HJ
Clin Adv Hematol Oncol; 2003 Dec; 1(12):735-40. PubMed ID: 16258478
[TBL] [Abstract][Full Text] [Related]
29. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection.
Wibe A; Syse A; Andersen E; Tretli S; Myrvold HE; Søreide O;
Dis Colon Rectum; 2004 Jan; 47(1):48-58. PubMed ID: 14719151
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of neoadjuvant radiochemotherapy in treatment of locally advanced low rectal cancer].
Yu BM; Zhang M; Wu WQ; Chen LW; Fu J; Fei CS; Shen Y
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):445-8. PubMed ID: 17686297
[TBL] [Abstract][Full Text] [Related]
31. Management and imaging of low rectal carcinoma.
Salerno G; Daniels I; Heald RJ; Brown G; Moran BJ
Surg Oncol; 2004; 13(2-3):55-61. PubMed ID: 15572087
[TBL] [Abstract][Full Text] [Related]
32. Surgical outcomes after total mesorectal excision for rectal cancer.
Chiappa A; Biffi R; Bertani E; Zbar AP; Pace U; Crotti C; Biella F; Viale G; Orecchia R; Pruneri G; Poldi D; Andreoni B
J Surg Oncol; 2006 Sep; 94(3):182-93; discussion 181. PubMed ID: 16900534
[TBL] [Abstract][Full Text] [Related]
33. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
34. Preservation of the continence function after intersphincteric resection using a prolapsing technique in the patients with low rectal cancer and its clinical prognosis.
Dai Y; Jiang JB; Bi DS; Jin ZT; Sun JZ; Hu SY
Chin Med J (Engl); 2008 Oct; 121(20):2016-20. PubMed ID: 19080267
[TBL] [Abstract][Full Text] [Related]
35. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial.
Kusters M; Marijnen CA; van de Velde CJ; Rutten HJ; Lahaye MJ; Kim JH; Beets-Tan RG; Beets GL
Eur J Surg Oncol; 2010 May; 36(5):470-6. PubMed ID: 20096534
[TBL] [Abstract][Full Text] [Related]
36. Results of long-term follow-up for transanal excision for rectal cancer.
Gonzalez QH; Heslin MJ; Shore G; Vickers SM; Urist MM; Bland KI
Am Surg; 2003 Aug; 69(8):675-8; discussion 678. PubMed ID: 12953825
[TBL] [Abstract][Full Text] [Related]
37. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
[TBL] [Abstract][Full Text] [Related]
38. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
[TBL] [Abstract][Full Text] [Related]
39. Preoperative assessment of the circumferential margin in rectal cancer is more informative in treatment planning than the T stage.
Wolberink SV; Beets-Tan RG; Nagtegaal ID; Wiggers T
Tech Coloproctol; 2006 Oct; 10(3):171-6. PubMed ID: 16969621
[TBL] [Abstract][Full Text] [Related]
40. [Surgical treatment of cancer at the beginning of the third millenium--based on the 2004 Krompecher Memorial Lecture of the Society of Hungarian Oncologists].
Balogh A
Magy Onkol; 2010 Jun; 54(2):101-15. PubMed ID: 20576585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
